HRMY

33.07

0.44% -0.145

Handel nachbörslich: 33.07

Harmony Biosciences Holdings Inc (HRMY)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HRMY? Forum Prognose

Schlusskurs vom Vortag:

$33.22

Offen:

$33.12

24-Stunden-Volumen:

400.91K

Relative Volume:

0.59

Marktkapitalisierung:

$1.89B

Einnahmen:

$656.11M

Nettoeinkommen (Verlust:

$114.99M

KGV:

13.44

EPS:

2.46

Netto-Cashflow:

$212.78M

1W Leistung:

-7.91%

1M Leistung:

-6.61%

6M Leistung:

+13.92%

1J Leistung:

+22.62%

1-Tages-Spanne:

$32.78

$33.31

1-Wochen-Bereich:

$32.55

$36.46

52-Wochen-Spanne:

$27.11

$41.61

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Firmenname

Harmony Biosciences Holdings Inc

Sektor

Healthcare (1196)

Branche

Biotechnology (683)

Telefon

(484) 539-9800

Adresse

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Mitarbeiter

246

Twitter

Nächster Verdiensttermin

2024-10-29

Neueste SEC-Einreichungen

HRMY's Discussions on Twitter

Vergleichen Sie HRMY mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HRMY	33.07	1.89B	656.11M	114.99M	212.78M	2.46
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-21	Eingeleitet	Citigroup	Buy
2024-01-02	Herabstufung	BofA Securities	Neutral → Underperform
2023-09-25	Herabstufung	Goldman	Neutral → Sell
2023-09-07	Eingeleitet	Berenberg	Buy
2023-04-20	Eingeleitet	BofA Securities	Neutral
2022-10-14	Hochstufung	Janney	Neutral → Buy
2022-10-14	Hochstufung	Jefferies	Hold → Buy
2022-08-03	Herabstufung	Jefferies	Buy → Hold
2022-07-13	Herabstufung	Goldman	Buy → Neutral
2022-07-07	Eingeleitet	Mizuho	Buy
2022-04-14	Eingeleitet	Cantor Fitzgerald	Overweight
2021-12-01	Eingeleitet	Oppenheimer	Outperform
2021-11-04	Eingeleitet	Raymond James	Outperform
2021-09-23	Eingeleitet	Needham	Buy
2021-03-29	Hochstufung	Goldman	Neutral → Buy
2020-09-14	Eingeleitet	Goldman	Neutral
2020-09-14	Eingeleitet	Jefferies	Buy
2020-09-14	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten

11:14 AM

First Week of July 2025 Options Trading For Harmony Biosciences Holdings (HRMY) - Nasdaq

11:14 AM

Nov 17, 2024

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Down 18.7% in October - MarketBeat

Nov 17, 2024

Nov 12, 2024

14,396 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Purchased by CWA Asset Management Group LLC - MarketBeat

Nov 12, 2024

Nov 11, 2024

Harmony Biosciences’ Common Stock Offering - Global Legal Chronicle

Nov 11, 2024

Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points (NASDAQ:HRMY) - Seeking Alpha

Nov 11, 2024

Nov 08, 2024

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 08, 2024

Nov 06, 2024

Harmony Biosciences director Antonio Gracias sells $139m in stock - Investing.com India

Nov 06, 2024

Nov 05, 2024

Marshman Fund Trust II sells $139.39 million in Harmony Biosciences stock - Investing.com

Nov 05, 2024

Harmony Biosciences director Antonio Gracias sells $139m in stock By Investing.com - Investing.com UK

Nov 05, 2024

AlphaCentric Advisors LLC Has $3.88 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat

Nov 05, 2024

There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings - Yahoo Canada Finance

Nov 05, 2024

Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 01, 2024

Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance

Nov 01, 2024

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? - Yahoo Finance

Nov 01, 2024

Oct 31, 2024

Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat - MSN

Oct 31, 2024

Harmony Biosciences Holdings Prices of Public Offering of Common Stock - citybiz

Oct 31, 2024

Harmony Biosciences chief commercial officer sells $870,018 in stock - Investing.com India

Oct 31, 2024

Harmony Biosciences chief commercial officer sells $870,018 in stock By Investing.com - Investing.com Canada

Oct 31, 2024

Latham Advises Harmony Biosciences Holdings, Inc. in Public Offering of Common Stock by Selling Shareholders - Latham & Watkins LLP

Oct 31, 2024

HRMY Makes Notable Cross Below Critical Moving Average - Nasdaq

Oct 31, 2024

Harmony Biosciences (NASDAQ:HRMY) Sees Strong Trading Volume Following Analyst Upgrade - MarketBeat

Oct 31, 2024

Cantor Fitzgerald Issues Positive Estimate for HRMY Earnings - MarketBeat

Oct 31, 2024

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024

Harmony Biosciences Holdings, Inc. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall St

Oct 31, 2024

Goldman Sachs maintains sell rating on HRMY stock with $28 target - Investing.com Canada

Oct 31, 2024

Oct 30, 2024